Table 2

Univariable analyses

hs-CRPhs-TnT
ReferentsCasesAll,
OR (95% CI)
No CAD,
OR (95% CI)
CAD,
OR (95% CI)
ReferentsCasesAll,
OR (95% CI)
No CAD,
OR (95% CI)
CAD,
OR (95% CI)
Q1164701.001.001.00248921.001.001.00
Q2163580.86 (0.57 to 1.30)0.54 (0.28 to 1.04)1.20 (0.69 to 2.08)77391.54 (0.96 to 2.47)1.17 (0.56 to 2.43)1.88 (1.00 to 3.54)
Q3160891.35 (0.91 to 2.01)0.96 (0.52 to 1.74)1.85 (1.08 to 3.18)161811.65 (1.10 to 2.47)1.46 (0.79 to 2.69)1.88 (1.08 to 3.26)
Q4160931.40 (0.94 to 2.06)0.99 (0.55 to 1.80)1.79 (1.05 to 3.05)161982.20 (1.43 to 3.40)2.09 (1.04 to 4.17)2.29 (1.29 to 4.07)
Z-scores
All (missing)6463101.13 (0.98 to 1.30)0.97 (0.78 to 1.21)1.24 (1.03 to 1.50)6463101.27 (1.10 to 1.47)1.40 (1.07 to 1.83)1.20 (1.01 to 1.43)
All6713361.13 (0.98 to 1.30)0.98 (0.79 to 1.21)1.24 (1.03 to 1.48)6713361.24 (1.07 to 1.43)1.39 (1.06 to 1.82)1.17 (0.98 to 1.38)
Men3491751.12 (0.92 to 1.37)0.83 (0.59 to 1.17)1.28 (1.00 to 1.64)3491751.29 (1.05 to 1.57)1.61 (1.04 to 2.50)1.19 (0.94 to 1.49)
Women3221611.14 (0.94 to 1.38)1.08 (0.82 to 1.43)1.19 (0.91 to 1.55)3221611.19 (0.97 to 1.45)1.27 (0.91 to 1.78)1.14 (0.88 to 1.47)
Surgery <5 years148740.96 (0.69 to 1.34)0.81 (0.50 to 1.33)1.03 (0.64 to 1.65)148741.57 (1.21 to 2.05)1.97 (1.24 to 3.15)1.34 (0.99 to 1.81)
Surgery ≥5 years5232621.17 (1.00 to 1.37)1.03 (0.80 to 1.31)1.27 (1.05 to 1.55)5232621.06 (0.88 to 1.28)1.01 (0.68 to 1.50)1.08 (0.86 to 1.34)
  • Values are the ORs with (95% CIs) for 1 (ln) SD increase (z-score) in the hs-CRP level or the hs-TnT level, as indicated. Z-scores with missing values replaced were used for all univariable calculations except when indicated.

  • Stratification for presence of CAD (yes/no), sex (men and women) and time between survey and surgery (less or more than 5 years).

  • Cut-offs for the quartiles (Q1–Q4) were: hs-CRP (mg/L; men and women): 0.5, 1.0, 2.5 and 0.6, 1.2, 2.3, respectively.

  • hs-TnT (ng/L; men and women combined) were 3.0, 3.7, 5.4. P values for indicating a trend: 0.026 for hs-CRP and 0.006 for hs-TnT.

  • CAD, coronary artery disease; hs-CRP, high-sensitivity C reactive protein; hs-TnT, high-sensitivity troponin T.